|
|
|
| home > white papers > Streamlining patient recruitment using EHR data |
|
|
 WHITE PAPERS |
|
|
|
|
Streamlining patient recruitment using EHR data
|
|
The field of (bio)pharmaceutical research is booming. Increasingly more innovative therapeutics are being developed with the ability to drastically improve the quality of life of millions of patients around the world. Rigorously testing each of these candidate drugs for their safety and efficacy is an essential part of the development process. As the number of clinical trials steadily increases, the search for patients who present a specific medical profile and are willing to participate intensifies.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
GSK Announces Positive Pivotal Phase III Data for its Respiratory Syncytial Virus (RSV) Vaccine Candidate for Older Adults
GSK plc (LSE/NYSE: GSK) today announced positive headline results
from a pre-specified efficacy interim analysis of the AReSVi 006 phase
III trial. The interim analysis was reviewed by an Independent Data
Monitoring Committee, and the primary endpoint was exceeded with no
unexpected safety concerns observed. AReSVi 006 is a phase III trial
investigating GSK’s respiratory syncytial virus (RSV) vaccine candidate
for adults aged 60 years and above.
More info >> |
|
 |
White Papers |
 |
|
R&D to Product: How to Reduce Costly Scale-Up Problems
Natoli Engineering Company, Inc.
When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >> |
|
|
|
